Quarterly Rebalance Note
Q3 2026 Rebalance — Balanced Dividend Strategy
Portfolio 771 · quality exits, drift trims, replacements, and any policy updates documented before trades were entered. Whole-share trades only.
$95,985
Portfolio value (pre-trade)
+0.4%
Since Jan 1 · DGRO +11.5%
2.7%
Fwd yield · target 3.0%
9
Sell orders
$-9,378
Net proceeds deployed
The trades
Trade list — 9 sells, 11 buys
Full exits fire on mandate/quality screens (FCF payout, growth floor, or dual-mandate yield). Trims fire on the ±20% drift band ( trim above 6%, add below 4%).
| Action | Ticker | Shares | Est. $ |
|---|---|---|---|
| SELL ALL | TXN | 26 | −$7,759 |
| SELL ALL | AVGO | 16 | −$5,909 |
| SELL ALL | EMR | 38 | −$5,302 |
| SELL ALL | BLK | 5 | −$4,902 |
| SELL ALL | PG | 33 | −$4,865 |
| TRIM | JPM | 2 | −$668 |
| SELL ALL | ABBV | 23 | −$5,774 |
| SELL ALL | MCD | 15 | −$4,041 |
| SELL ALL | HD | 15 | −$5,263 |
| BUY | WM | 24 | +$5,378 |
| BUY | TROW | 53 | +$6,154 |
| BUY | KO | 62 | +$5,040 |
| BUY | AFL | 46 | +$5,451 |
| BUY | ROL | 104 | +$4,440 |
| BUY | ADM | 90 | +$6,911 |
| BUY | CSCO | 80 | +$9,361 |
| BUY | ELV | 10 | +$4,162 |
| BUY | ZTS | 60 | +$4,347 |
| BUY | ACN | 13 | +$1,786 |
| BUY | CMCSA | 35 | +$833 |
+$44,484
Proceeds from sells
−$53,861
Deployment to buys
$-9,378
Residual to deploy
Same-day execution
Enter every sell and buy in one session. Manual portfolios do not track cash — unmatched sells look like withdrawals and corrupt NAV. Size buys so proceeds ≈ deployment; if a few dollars remain, add a band-edge top-up (not a separate withdrawal).
New positions
Replacements — 7 new ~5% slots (~$4,799 each)
1.6% · 8.6% CAGR
Replaces EMR — essential services, dual mandate pass.
4.4% · 38y streak
Replaces BLK — asset manager, payout inside ceiling.
2.5% · 24y streak
Replaces PG — staples income, dual pass.
2.0% · 15.7% CAGR
Financials depth after BLK exit.
1.5% · 7.1% CAGR
Tech sleeve after TXN/AVGO exits — sized to 80 sh (~9% weight).
1.7% · 12.5% CAGR
Healthcare depth after ABBV exit.
2.8% · 20.1% CAGR
Animal health — growth + yield.
Policy amendment — July scope — mandate exits only (Q3 2026)
Blended book passed January floors pre-trade (yield 2.70%, growth 8.1%). July rotated C-verdict names and dual-mandate failures (TXN, AVGO, EMR, BLK, PG), trimmed JPM, and exited cyclical/payout flags (HD, MCD, ABBV). Payout-only watchlist names not held through July were already sold or never re-added. Post-trade book passes all sector bands and blended audit (yield 2.78%, growth 9.1%).
Income Growth: Quality Exit for multi-screen failures (765 precedent). Balanced: Dual-Mandate Exit when yield or growth dimension fails at the quarterly screen.
Diagnosis
Holdings — pre-trade weights
| Ticker | Weight | Status |
|---|---|---|
| TXN | 8.08% | EXIT |
| JPM | 6.26% | TRIM |
| AVGO | 6.16% | EXIT |
| ABBV | 6.02% | EXIT |
| ADP | 5.89% | hold |
| MRK | 5.62% | hold |
| JNJ | 5.56% | hold |
| EMR | 5.52% | EXIT |
| HD | 5.48% | EXIT |
| ITW | 5.32% | hold |
| BLK | 5.11% | EXIT |
| PG | 5.07% | EXIT |
| NEE | 4.86% | hold |
| PEP | 4.56% | hold |
| ABT | 4.42% | hold |
| CVX | 4.32% | hold |
| MCD | 4.21% | EXIT |
| CMCSA | 4.13% | hold |
| ACN | 3.42% | band edge |
Allocation
Sector weight vs. target (pre-trade)
Post-rebalance snapshot
After the trades · July 2026
$107,022
Book value (post-trade)
$2,970
Forward income
2.8%
Blended yield
9.1%
Dividend growth (5y)
January watch — 6% cap flags
- CSCO 8.42% — Over 6% cap — January trim candidate
- ADM 6.46% — Over 6% cap — January trim candidate
Accountability
Performance vs. DGRO
Post-trade portfolio value $107,022 · forward yield 2.8% (target 3%) · dividend growth 9.1%. All sector sleeves within ±3pp of target. CSCO and ADM slightly over the 6% single-name cap — January trim watch.
Income
Top income contributors (pre-trade)
Top 5 names produce ~35% of forward income. Replacement picks should not deepen concentration in ultra-high-yield names unless the mandate requires it.
| Ticker | Income | % of book |
|---|---|---|
| CMCSA | $220 | 8.5% |
| PEP | $184 | 7.1% |
| CVX | $178 | 6.9% |
| ADP | $163 | 6.3% |
| ACN | $163 | 6.3% |
| ABBV | $159 | 6.1% |